Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs

PURPOSE: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced permeability and retention (EPR) effect in neoplasm lesions. This study demonstrated that tumor burden determines the tumor uptake, and also the tumor response, in cancer treatment with PEGylated lip...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Yu, Kao, Hao-Wen, Li, Jia-Je, Hwang, Jeng-Jong, Tseng, Yun-Long, Lin, Wuu-Jyh, Lin, Ming-Hsien, Ting, Gann, Wang, Hsin-Ell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651236/
https://www.ncbi.nlm.nih.gov/pubmed/23675454
http://dx.doi.org/10.1371/journal.pone.0063078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651236/
https://www.ncbi.nlm.nih.gov/pubmed/23675454
http://dx.doi.org/10.1371/journal.pone.0063078

Ejemplares similares